Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Regulation of T-cell immune exhaustion and cancer immunotherapy
Shingo Eikawa
, Heiichiro Udono
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Regulation of T-cell immune exhaustion and cancer immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
T Cells
100%
CD8+ T Cells
100%
Cancer Immunotherapy
100%
Immune Exhaustion
100%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
33%
Interferon-α (IFN-α)
16%
Viral
16%
Apoptosis
16%
Cancer Cells
16%
Tumor Necrosis Factor-α
16%
Interleukin-2
16%
Antitumor Effect
16%
Tumor Antigen
16%
T Cell Receptor
16%
Immune Function
16%
Programmed Death-ligand 1 (PD-L1)
16%
Activated T Cells
16%
Promising Treatment
16%
Virus-associated Cancer
16%
Lymphocyte Activation gene-3 (LAG-3)
16%
Phenotypic Change
16%
Anti-PD-1
16%
Anti-cytotoxic
16%
Advanced Melanoma
16%
T Cell Immunoglobulin mucin-3
16%
Chronic Infectious Diseases
16%
Negative Signal
16%
Exhaustion Marker
16%
Immunology and Microbiology
T Cell
100%
Cytotoxic T-Cell
100%
Cancer Immunotherapy
100%
interferon
16%
T Cell Receptor
16%
Interleukin 2
16%
Tumor Necrosis Factor
16%
Cancer Cell
16%
Infectious Agent
16%
Tumor Antigen
16%
Intravenous Immunoglobulin
16%
CTLA-4
16%
Programmed Death 1 Receptor
16%
Mucin
16%
Lymphocyte Activation
16%
Cytotoxic T Lymphocyte Antigen 4 Antibody
16%
Programmed Cell Death
16%